Leonard Glass

Leonard Glass

doctor United States

Dr. Leonard Glass serves as the Senior Vice President of Global Medical Affairs at Eli Lilly, where he oversees research and development in pharmacological treatments. He expressed satisfaction with the results of a recent clinical trial showing that Munjaro led to significantly greater weight loss compared to its competitor, Wegovy, positioning it as a leading treatment option for obesity.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Liechtenstein Liechtenstein: Leonard Glass is the senior vice president of global medical affairs at Lilly and commented on the effectiveness of tirzepatida for treating obesity. 9

O Estado de S. Paulo (Estadão): Estudo compara perda de peso de pacientes com obesidade tratados com Mounjaro e Wegovy; veja dados

Israel Israel: Dr. Leonard Glass expressed satisfaction with the data from the comparative study on Monjaro. 8

ידיעות אחרונות (Yedioth Ahronoth / ynet): זריקת הרזיה במבחן: מונג'רו או וויגובי